Alcoholic Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Alcoholic Hepatitis Pipeline Drugs Market Overview
The Alcoholic Hepatitis pipeline drugs market report provides a comprehensive overview of the therapeutics under development for Alcoholic Hepatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects.
Alcoholic Hepatitis Pipeline Drugs Market by Key Targets
In the Alcoholic Hepatitis pipeline drugs market, the key targets are Asialoglycoprotein Receptor 1, Bile Acid Receptor, DNA, DNA (Cytosine 5) Methyltransferase 1, DNA (Cytosine 5) Methyltransferase 3A, E3 Ubiquitin Protein Ligase RNF43, Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA, Interleukin 1 Beta, Interleukin 22 Receptor, and microRNA 155.
For more target insights, download a free report sample
Key MoA in the Alcoholic Hepatitis Pipeline Drugs Market
The key mechanisms of action are Bile Acid Receptor Agonist, DNA (Cytosine 5) Methyltransferase 1 Inhibitor, DNA (Cytosine 5) Methyltransferase 3A Inhibitor, DNA Synthesis Inhibitor, Gamma-Aminobutyric Acid Type A Receptor Subunit (GABAAgonist, Interleukin 1 Beta Inhibitor, Interleukin 22 Receptor Agonist, and microRNA 155 Inhibitor.
To get more insights on key MoA, download a free sample report
Alcoholic Hepatitis Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Alcoholic Hepatitis pipeline drug market are oral, intravenous, subcutaneous, intraarticular, intralesional, intramuscular, parenteral, and topical. Oral has the maximum number of pipeline products.
Alcoholic Hepatitis Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Alcoholic Hepatitis Pipeline Drugs Market
The key molecule types in the Alcoholic Hepatitis pipeline drugs market are small molecule, fusion protein, cell therapy, gene therapy, monoclonal antibody, oligonucleotide, and recombinant protein. Small molecule has the maximum number of pipeline products.
Alcoholic Hepatitis Pipeline Drugs Market, by Molecule Types
To get more insights on key molecule types, download a free sample report
Major Companies in the Alcoholic Hepatitis Pipeline Drugs Market
Some of the major companies in the Alcoholic Hepatitis pipeline drugs market are DURECT Corp, Evive Biotech, Hepatx Corp, ImmuneMed Inc, Intercept Pharmaceuticals Inc, Novartis AG, Odan Laboratories Ltd, Pattern Therapeutics, PharmaKing Co Ltd, and Rejuvenation Technologies Inc.
Alcoholic Hepatitis Pipeline Drugs Market Overview
Key Targets | Asialoglycoprotein Receptor 1, Bile Acid Receptor, DNA, DNA (Cytosine 5) Methyltransferase 1, DNA (Cytosine 5) Methyltransferase 3A, E3 Ubiquitin Protein Ligase RNF43, Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA, Interleukin 1 Beta, Interleukin 22 Receptor, and microRNA 155 |
Key Mechanisms of Action | Bile Acid Receptor Agonist, DNA (Cytosine 5) Methyltransferase 1 Inhibitor, DNA (Cytosine 5) Methyltransferase 3A Inhibitor, DNA Synthesis Inhibitor, Gamma-Aminobutyric Acid Type A Receptor Subunit (GABAAgonist, Interleukin 1 Beta Inhibitor, Interleukin 22 Receptor Agonist, and microRNA 155 Inhibitor |
Key Routes of Administration | Oral, Intravenous, Subcutaneous, Intraarticular, Intralesional, Intramuscular, Parenteral, and Topical |
Key Molecule Types | Small Molecule, Fusion Protein, Cell Therapy, Gene Therapy, Monoclonal Antibody, Oligonucleotide, and Recombinant Protein |
Major Companies | DURECT Corp, Evive Biotech, Hepatx Corp, ImmuneMed Inc, Intercept Pharmaceuticals Inc, Novartis AG, Odan Laboratories Ltd, Pattern Therapeutics, PharmaKing Co Ltd, and Rejuvenation Technologies Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Alcoholic Hepatitis
- The pipeline guide reviews pipeline therapeutics for Alcoholic Hepatitis by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alcoholic Hepatitis therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alcoholic Hepatitis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Alcoholic Hepatitis
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alcoholic Hepatitis
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alcoholic Hepatitis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Evive Biotech
Hepatx Corp
ImmuneMed Inc
Intercept Pharmaceuticals Inc
Novartis AG
Odan Laboratories Ltd
Pattern Therapeutics
PharmaKing Co Ltd
Rejuvenation Technologies Inc
Surrozen Inc
Vectus Biosystems Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Alcoholic Hepatitis pipeline drug market?
In the Alcoholic Hepatitis pipeline drugs market the key targets are Asialoglycoprotein Receptor 1, Bile Acid Receptor, DNA, DNA (Cytosine 5) Methyltransferase 1, DNA (Cytosine 5) Methyltransferase 3A, E3 Ubiquitin Protein Ligase RNF43, Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA, Interleukin 1 Beta, Interleukin 22 Receptor, and microRNA 155.
-
What are the key mechanisms of action in the Alcoholic Hepatitis pipeline drugs market?
In the Alcoholic Hepatitis pipeline drugs market the key mechanisms of action are Bile Acid Receptor Agonist, DNA (Cytosine 5) Methyltransferase 1 Inhibitor, DNA (Cytosine 5) Methyltransferase 3A Inhibitor, DNA Synthesis Inhibitor, Gamma-Aminobutyric Acid Type A Receptor Subunit (GABAAgonist, Interleukin 1 Beta Inhibitor, Interleukin 22 Receptor Agonist, and microRNA 155 Inhibitor.
-
What are the key routes of administration in the Alcoholic Hepatitis pipeline drugs market?
The key routes of administration in the Alcoholic Hepatitis pipeline drug market are Oral, Intravenous, Subcutaneous, Intraarticular, Intralesional, Intramuscular, Parenteral, and Topical. Oral has the maximum number of pipeline products.
-
What are the key molecule types in the Alcoholic Hepatitis pipeline drugs market?
The key molecule types in the Alcoholic Hepatitis pipeline drug market are Small Molecule, Fusion Protein, Cell Therapy, Gene Therapy, Monoclonal Antibody, Oligonucleotide, and Recombinant Protein.
-
What are the major companies in the Alcoholic Hepatitis pipeline drugs market?
In the Alcoholic Hepatitis pipeline drugs market the major companies are DURECT Corp, Evive Biotech, Hepatx Corp, ImmuneMed Inc, Intercept Pharmaceuticals Inc, Novartis AG, Odan Laboratories Ltd, Pattern Therapeutics, PharmaKing Co Ltd, and Rejuvenation Technologies Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.